Interleukin-1 inhibition can be safely continued around the time of pericardiectomy to prevent rebound inflammation in patients with chronic constrictive pericarditis.
Does perioperative continuation of IL-1 blockade safely prevent rebound inflammation in patients with chronic constrictive pericarditis undergoing pericardiectomy?
Perioperative continuation of IL-1 blockade is safe and prevents rebound inflammation in patients undergoing pericardiectomy for chronic constrictive pericarditis.
Absolute Event Rate: 0% vs 0%
Recognizing the transition from inflammation to fixed constriction is essential for directing patients toward surgical evaluation. IL-1 inhibition can be continued safely around the time of pericardiectomy to prevent rebound inflammation.
Issa et al. (Wed,) reported a other. Interleukin-1 inhibition can be safely continued around the time of pericardiectomy to prevent rebound inflammation in patients with chronic constrictive pericarditis.